☰

Stacy A. Decker, Ph.D. - Publications

Affiliations: 
2012 Neuroscience University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Neuroscience Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Soroceanu L, Matlaf L, Khan S, Akhavan A, Singer E, Bezrookove V, Decker S, Ghanny S, Hadaczek P, Bengtsson H, Ohlfest J, Luciani-Torres MG, Harkins L, Perry A, Guo H, et al. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma. Cancer Research. 75: 3065-76. PMID 26239477 DOI: 10.1158/0008-5472.Can-14-3307  0.588
2012 Agarwal S, Mittapalli RK, Zellmer DM, Gallardo JL, Donelson R, Seiler C, Decker SA, Santacruz KS, Pokorny JL, Sarkaria JN, Elmquist WF, Ohlfest JR. Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agents. Molecular Cancer Therapeutics. 11: 2183-92. PMID 22891038 DOI: 10.1158/1535-7163.Mct-12-0552  0.618
2012 Murphy KA, Lechner MG, Popescu FE, Bedi J, Decker SA, Hu P, Erickson JR, O'Sullivan MG, Swier L, Salazar AM, Olin MR, Epstein AL, Ohlfest JR. An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4657-68. PMID 22781551 DOI: 10.1158/1078-0432.Ccr-12-0990  0.567
2011 Fujita M, Kohanbash G, Fellows-Mayle W, Hamilton RL, Komohara Y, Decker SA, Ohlfest JR, Okada H. COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Research. 71: 2664-74. PMID 21324923 DOI: 10.1158/0008-5472.Can-10-3055  0.616
2011 Fujita M, Kohanash G, Fellows-Mayle W, Hamilton RL, Decker SA, Ohlfest JR, Okada H. Abstract 1788: COX-2 blockade suppresses gliomagenesis by inhibiting CCL2-mediated accumulation of myeloid-derived suppressor cells Cancer Research. 71: 1788-1788. DOI: 10.1158/1538-7445.Am2011-1788  0.543
2010 Fujita M, Scheurer ME, Decker SA, McDonald HA, Kohanbash G, Kastenhuber ER, Kato H, Bondy ML, Ohlfest JR, Okada H. Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3409-19. PMID 20472682 DOI: 10.1158/1078-0432.Ccr-10-0644  0.546
2010 Fujita M, Decker SA, Popescu F, McDonald HA, Kohanbash G, Ohlfest JR, Okada H. Abstract 1359: COX2 blockade suppresses glioma-genesis by promoting anti-glioma immunosurveillance Cancer Research. 70: 1359-1359. DOI: 10.1158/1538-7445.Am10-1359  0.545
2009 Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, Gallardo JL, Long C, Demorest ZL, Zamora EA, Low WC, SantaCruz K, Largaespada DA, Ohlfest JR. De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Research. 69: 431-9. PMID 19147555 DOI: 10.1158/0008-5472.Can-08-1800  0.619
Show low-probability matches.